ATMOS EN. CORP./ US0495601058 /
16.05.2024 14:19:09 | Изменение +0.90 | Объем сделки | Бид14:19:09 | Предложение14:19:09 | Рыночная капитализация | Дивидендная доходность | Коэффициент Цена/Доход |
---|---|---|---|---|---|---|---|
108.25EUR | +0.84% | - Оборот: - |
108.25Величина цены спроса: - | 108.60Величина цены предложения: - | 16.33 млрдEUR | - | - |
GlobeNewswire
14:15
Hip-Hop Duo Flyana Boss Joins Musicians On Call & Men’s Wearhouse in Making Prom Memories With Pedia...
GlobeNewswire
14:15
Claritas HealthTech Extends Claritas iPET™ capability with iPETcertum™ for Automated Lesion Detectio...
GlobeNewswire
14:15
Imperial Petroleum Inc. Reports First Quarter 2024 Financial and Operating Results
GlobeNewswire
14:05
LED Lighting and EV Charging Solutions Provider Orion Previews FY 2024 Results in Anticipation of it...
GlobeNewswire
14:05
MatrixCare Joins Health Gorilla’s Qualified Health Information Network (QHIN) to Enhance Patient Dat...
GlobeNewswire
14:05
NKGen Biotech Announces Upcoming Presentation on Autologous NK Cell Therapy at the 5th International...
GlobeNewswire
14:03
Meltwater Integrates Influencer Marketing Analytics, Workflows Within Social Suite, in an Industry F...
GlobeNewswire
14:01
Ardelyx Presents Additional Data at the NKF 2024 Spring Clinical Meetings on XPHOZAH® (tenapanor)
GlobeNewswire
14:01
Ocean Biomedical, Inc. (NASDAQ: OCEA) Announces Patent Allowance for Malaria Antibodies That Have Po...
GlobeNewswire
14:00
Fortress Biotech to Participate in the Alliance Global Partners’ (A.G.P.) Virtual Healthcare Company...
GlobeNewswire
14:00
Allegro MicroSystems to Present at TD Cowen’s Technology, Media & Telecom Conference on May 29
GlobeNewswire
14:00
Oragenics, Inc. Prepares Intranasal Pharmaceutical, ONP-002, for Phase II Concussion Trial
GlobeNewswire
14:00
Akari Therapeutics Reports First Quarter 2024 Financial Results and Recent Highlights
- Первая страница
- Назад
- 1
- 2
- 3
- 4
- Следующий
- Последняя страница